Sorin’s profits climbed by 47.5% year on year despite sales slowdown
Following its launch in Europe earlier this year, St Jude’s Ilumien OCT/FFR Coronary Artery Disease diagnostic tool
St Jude CEO Daniel Starks blasted rival Medtronic in 3rd quarter earnings call.
Data presented today at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc., shows positive results for the Medtronic Reveal® XT Insertable Cardiac Monitor (ICM).
Transoma Medical, manufacturer of Sleuth, the first wireless, automated implantable cardiac monitoring system has now received FDA marketing clearance on its second-generation product, Sleuth AT™ (Advanced Trending) Cardiac Monitoring System.